Clinical Trial Update: S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial (S0310) evaluating a vaccine therapy for stage IIIB or stage IV bronchioloalveolar lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED